STOCK MARKET BSE NSE

Sun Pharma Brings to Closure Ranbaxy Merger

India\'s largest pharma company Sun Pharmaceutical Industries on Wednesday announced the closure of its merger with Ranbaxy Laboratories saying the integration will deliver synergies worth $250 million (over Rs.1,500 crore) in three years.

Published: 26th March 2015 07:59 AM  |   Last Updated: 26th March 2015 07:59 AM   |  A+A-

By IANS

MUMBAI: India's largest pharma company Sun Pharmaceutical Industries on Wednesday announced the closure of its merger with Ranbaxy Laboratories saying the integration will deliver synergies worth $250 million (over Rs.1,500 crore) in three years.

"The merger has created a combined entity which has much more managerial capability. We will look to retain and nurture the talent," Sun Pharma managing director Dilip Shanghvi told reporters here.

He said the company would invest more than $300 million (over Rs.1,800 crore) in research and development in 2015, which would be six to seven percent of the combined revenue.

Following the merger, Ranbaxy will be delisted from Indian stock exchanges while each Ranbaxy shareholders will receive 0.8 share of Sun Pharma for each share of Ranbaxy.

The merger will make Sun Pharma the largest pharmaceutical company in India with a market share of 9.2 percent and sales of $1.1 billion, as well as the world's fifth largest maker of generic drugs after Teva, Sandoz, Activas and Mylan.

The Punjab and Haryana High Court had approved the merger earlier this month, while the US Federal Trade Commission (FTC) had approved the merger in January 2015.

On March 23, the Competition Commission of India (CCI) had approved the Sun Pharma and Ranbaxy sale of seven brands to Emcure Pharma to comply with the conditional nod for their merger.

More from Business.

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

IPL_2020
flipboard facebook twitter whatsapp